|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.33 USD | -4.15% |
|
-2.38% | +7.07% |
| 07-07 | RBC Capital Adjusts PTC Therapeutics Price Target to $85 From $82, Maintains Sector Perform Rating | MT |
| 06-29 | PTC Therapeutics, Inc.(NasdaqGS:PTCT) added to Russell 2000 Value-Defensive Index | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 89.55 | 89.55 | 85.99 |
| Spread/Res. | -9.18% | -9.18% | -5.42% |
| Spread/Supp. | +5.83% | +11.00% | +79.22% |
| Support | 76.85 | 73.27 | 45.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PTCT Stock
- Charts PTC Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
